Gliknik Competitors and Similar CompaniesClear all

Gliknik's competitors and similar companies include Metys Pharmaceuticals, Scopus BioPharma and Mersana Therapeutics.
Gliknik
Gliknik
Gliknik is a biopharmaceutical company creating therapies for people living with cancer and immune disorders.
Metys Pharmaceuticals
Metys Pharmaceuticals
Metys Pharmaceuticals is a company that provides treatment for chemotherapy-induced peripheral neuropathy, a side effect of several cancer treatments.
Scopus BioPharma
Scopus BioPharma
Scopus BioPharma (formerly known as Project18) is a biopharmaceutical company developing therapeutics targeting diseases with unmet medical needs.
Mersana Therapeutics
Mersana Therapeutics
Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms.
Founding Date
Founding Date
2007
Founding Date
2013
Founding Date
2017
Founding Date
2005
Type
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Baltimore, US HQ
Locations
Basel, CH HQ
Basel, CH
Locations
New York, US HQ
Locations
Cambridge, US HQ
Employees
Employees
9
Employees
2
Employees
1344% increase
Employees
11033% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
21 k
Valuation ($)
250.3 m

Financial

Net income
Net income
N/A
Net income
N/A
Net income
($11.7m) (FY, 2022)
Net income
($69.2m) (FY, 2024)

Funding

Total funding raised
Total funding raised
$ 65.1m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 219.5m
For sources of this data, please see the company profile

View Company Profiles

Metys Pharmaceuticals
HQ
Basel, CH
Employees
2

Metys Pharmaceuticals is a company that provides treatment for chemotherapy-induced peripheral neuropathy, a side effect of several cancer treatments.

View company
Scopus BioPharma
HQ
New York, US
Employees
13↑ 44% increase

Scopus BioPharma (formerly known as Project18) is a biopharmaceutical company developing therapeutics targeting diseases with unmet medical needs.

View company
Mersana Therapeutics
HQ
Cambridge, US
Employees
110↑ 33% increase

Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms.

View company